Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology.
- DOI
- 10.1097/hep.0000000000000980
- Published
- 2025 Mar 1
- Container
- Hepatology (Baltimore, Md.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/hep.0000000000000980,
title = {Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology.},
author = {Ratziu V and Yilmaz Y and Lazas D and Friedman SL and Lackner C and Behling C and Cummings OW and Chen L and Petitjean M and Gilgun-Sherki Y and Gorfine T and Kadosh S and Eyal E and Sanyal AJ},
year = {2025},
journal = {Hepatology (Baltimore, Md.)},
doi = {10.1097/hep.0000000000000980},
url = {https://doi.org/10.1097/hep.0000000000000980}
}RIS
TY - JOUR TI - Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. AU - Ratziu V AU - Yilmaz Y AU - Lazas D AU - Friedman SL AU - Lackner C AU - Behling C AU - Cummings OW AU - Chen L AU - Petitjean M AU - Gilgun-Sherki Y AU - Gorfine T AU - Kadosh S AU - Eyal E AU - Sanyal AJ PY - 2025 JO - Hepatology (Baltimore, Md.) DO - 10.1097/hep.0000000000000980 UR - https://doi.org/10.1097/hep.0000000000000980 ER -
APA
V, R., Y, Y., D, L., SL, F., C, L., C, B., OW, C., L, C., M, P., Y, G., T, G., S, K., E, E., & AJ, S. (2025). Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology.. Hepatology (Baltimore, Md.). https://doi.org/10.1097/hep.0000000000000980
Source records
- pubmed · retrieved 2026-09-26T20:06:58.648Z